From October 1, 2023 to February 8, 2024, the company has repurchased 194,554 shares, representing 0.12% for CNY 20.06 million. With this, the company has completed the repurchase of 496,600 shares, representing 0.32% for CNY 49.98 million under the buyback announced on August 11, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
114.5 CNY | +0.36% | -7.46% | -9.05% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.05% | 2.48B | |
+0.13% | 28.85B | |
+22.50% | 24.98B | |
+4.67% | 11.04B | |
+18.43% | 4.44B | |
-8.30% | 3.81B | |
+2.12% | 3.38B | |
+0.07% | 2.99B | |
+25.54% | 2.78B | |
+1.61% | 2.3B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.